Literature DB >> 22212899

B-cells and IL-4 promote methylcholanthrene-induced carcinogenesis but there is no evidence for a role of T/NKT-cells and their effector molecules (Fas-ligand, TNF-α, perforin).

Thomas Kammertoens1, Zhihai Qin, Dana Briesemeister, Albert Bendelac, Thomas Blankenstein.   

Abstract

Mice deficient either in subtypes of immune cells, cytokines or lytic pathways have been subjected to chemical carcinogenesis by methylcholanthrene to evaluate whether these components of the immune system affect tumor development. Inbred mice of the same genotype but from different sources differed in tumor development in magnitude comparable to that previously attributed to differences in immunocompetence. This suggested that genetic drift between separate inbred colonies of mice and/or environmental factors (e.g., transport of the animals) influenced carcinogenesis. Therefore, littermates were used as control in subsequent experiments. Although deficiency of T-cells, NKT-cells, perforin, Fas-ligand, TNF-α-receptor failed to reveal significant differences in tumor development, the presence of B-cells and IL-4 enhanced tumor development under similar experimental conditions.
Copyright © 2011 UICC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22212899     DOI: 10.1002/ijc.27411

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

Review 1.  Targeting neoantigens to augment antitumour immunity.

Authors:  Mark Yarchoan; Burles A Johnson; Eric R Lutz; Daniel A Laheru; Elizabeth M Jaffee
Journal:  Nat Rev Cancer       Date:  2017-02-24       Impact factor: 60.716

Review 2.  The determinants of tumour immunogenicity.

Authors:  Thomas Blankenstein; Pierre G Coulie; Eli Gilboa; Elizabeth M Jaffee
Journal:  Nat Rev Cancer       Date:  2012-03-01       Impact factor: 60.716

3.  CXCR3 deficiency enhances tumor progression by promoting macrophage M2 polarization in a murine breast cancer model.

Authors:  Steve Oghumu; Sanjay Varikuti; Cesar Terrazas; Dmitri Kotov; Mohd W Nasser; Catherine A Powell; Ramesh K Ganju; Abhay R Satoskar
Journal:  Immunology       Date:  2014-09       Impact factor: 7.397

Review 4.  Invariant natural killer T cells as sensors and managers of inflammation.

Authors:  Luc Van Kaer; Vrajesh V Parekh; Lan Wu
Journal:  Trends Immunol       Date:  2012-09-25       Impact factor: 16.687

5.  Natural killer T cells: drivers or passengers in preventing human disease?

Authors:  Stuart P Berzins; David S Ritchie
Journal:  Nat Rev Immunol       Date:  2014-08-08       Impact factor: 53.106

6.  Impact of TCR Diversity on the Development of Transplanted or Chemically Induced Tumors.

Authors:  Hans Schreiber; Matthias Leisegang; Karin Schreiber; Theodore G Karrison; Steven P Wolf; Kazuma Kiyotani; Madeline Steiner; Eric R Littmann; Eric G Pamer; Thomas Kammertoens
Journal:  Cancer Immunol Res       Date:  2019-12-12       Impact factor: 11.151

7.  IL-13 but not IL-4 signaling via IL-4Rα protects mice from papilloma formation during DMBA/TPA two-step skin carcinogenesis.

Authors:  Michael Rothe; David Quarcoo; Anna A Chashchina; Svetlana V Bozrova; Zhihai Qin; Sergei A Nedospasov; Thomas Blankenstein; Thomas Kammertoens; Marina S Drutskaya
Journal:  Cancer Med       Date:  2013-10-22       Impact factor: 4.452

8.  New Directions for Natural Killer T Cells in the Immunotherapy of Cancer.

Authors:  Luc Teyton
Journal:  Front Immunol       Date:  2017-11-08       Impact factor: 7.561

Review 9.  CD8+ T cell differentiation and dysfunction in cancer.

Authors:  Mary Philip; Andrea Schietinger
Journal:  Nat Rev Immunol       Date:  2021-07-12       Impact factor: 108.555

10.  A Lower Proportion of Regulatory B Cells in Patients with Henoch-Schoenlein Purpura Nephritis.

Authors:  Xintong Hu; Jiandong Tai; Zhihui Qu; Songchen Zhao; Li Zhang; Man Li; Xiguang Sun; Yanfang Jiang
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.